Navigation Links
PLC Systems Reports First Quarter 2012 Results
Date:5/15/2012

d at this event, we are engaging with all of our distributors as well as many thought leaders in this space. Between these efforts and the latest supportive scientific findings for our technology, we believe sales of RenalGuard going forward will grow. Each new scientific study provides more evidence that RenalGuard can truly help prevent the acute kidney injury known as contrast-induced nephropathy. There has been no diminishment in the need for this solution, with more and more patients with impaired kidney function requiring diagnostic procedures where contrast is utilized."

He continued, "As a company, during the first few months of 2012, we have made major progress on achieving critical milestones, including the following:

  • We are continuing enrollment of patients in our U.S. pivotal trial of RenalGuard, with eight sites currently in operation and more to be initiated. The company plans to provide an enrollment update as it approaches the interim analysis.
  • We announced approval to market RenalGuard in Brazil, the largest country in South America and the fifth largest in the world, as well as in Israel, where we signed a new distributor and a prominent CIN investigator successfully completed the first case using RenalGuard in Israel.
  • An additional investigator-sponsored study on RenalGuard's longer term efficacy compared to conventional alternatives by a group of cardiologists at the University of Modena in Italy was reported in an abstract presented at ACC 2012 in March.
  • The results from the MYTHOS investigator-sponsored trial, as well as the results of PLC's pilot safety study, were published in peer-reviewed medical journals.
  • RenalGuard was demonstrated at two major international medical meetings, in Israel and in Germany, increasing its visibility with more practitioners.
  • These developments are all important steps in enabling RenalGuard to reach a broader patient base worldwide, and are critical
    '/>"/>

    SOURCE PLC Systems
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Veeva Systems Announces Dramatic Growth in Europe
    2. Surgical Information Systems Recognizes Clients for Financial, Clinical, and Operational Improvements
    3. New Forecast Shows Patient Monitoring Systems Market to Reach $18.9 billion by 2016
    4. Middle East and Africa Endoscopy Devices Market Outlook to 2017 - Flexible Endoscopes, Rigid Endoscopes, Endoscopy Visualization Systems, Capsule Endoscope Systems and Others
    5. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
    6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
    7. Leica Biosystems Receives FDA Approval for the Fully Automated Bond Oracle™ HER2 IHC System on the Leica BOND-MAX
    8. Delcath Systems, Inc. Secures $20 Million Credit Facility
    9. GeckoSystems Evaluates Europes Robotic Wheelchair Market
    10. PLC Systems RenalGuard to be Demonstrated at Cardiology Meetings in Germany and Israel
    11. Puritan Medical Products Company Launches New Diagnostic Collection and Transport Systems
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/22/2014)... Influenza will affect as many as 200,000 people this year ... as high as 49,000 people.  The main way ... to person in respiratory droplets of coughs and sneezes. ... kills much fewer people each year than the Flu. The ... sweat, saliva, blood and other bodily fluids. The Ebola virus ...
    (Date:10/22/2014)... -- Sanomedics International Holdings, Inc. (OTCQB: SIMH) – According ... Data Services, demand for thermometers is expected to grow ... demand for more accurate digital thermometers continues.  ... market for thermometers, and one of the companies serving ... Inc. Sanomedics International Holdings designs, develops, markets, ...
    (Date:10/22/2014)... YORK , Oct. 22, 2014 Provectus ... dermatology therapies. PV-10, its novel investigational drug for cancer, ... potential for systemic side effects. Its oncology focus is ... Provectus has completed phase 2 trials of PV-10 as ... a topical treatment for atopic dermatitis and psoriasis. ...
    Breaking Medicine Technology:WholeHealth Products is proud to be releasing its Influenza A and B combo test, on the heels of the announcing of its phase 2 completion of the Rapid Ebola Test 2Sanomedics International Holdings Analyst Report: Taking Some Heat by BrokerBank Securities, Inc. 2Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2
    ... The Society for Biomolecular Sciences, now officially the ... and Screening (SLAS), invites students, graduate students, post-doctoral associates ... Travel Award to be used for the SBS 17th ... FL, USA. Applicants must be the primary ...
    ... Nov. 4, 2010 Amylin Pharmaceuticals, Inc. (Nasdaq: ... Conference in Phoenix, Arizona on Thursday, November 11, 2010 at ... M. Bradbury, president and chief executive officer of Amylin Pharmaceuticals, ... be webcast live through the "Investors" section of Amylin,s corporate ...
    Cached Medicine Technology:Applications Now Being Accepted for SBS 17th Annual Conference & Exhibition Academic Travel Awards 2
    (Date:10/22/2014)... Best Cheap Hosting USA is among the most distinguished ... announced that iPower ( http://www.best-cheap-hosting-usa.com/go/iPower/ ) is the best ... world. , “iPower is one of the most reliable ... kinds of useful products for new and old clients. ... service and a number of features which will appeal ...
    (Date:10/22/2014)... 22, 2014 Richard Carlson, Managing Partner ... leader with over 25 years experience. Mr. Carlson ... the areas related to EDI, B2B Commerce, RFID and ... Editorial Advisory Board member for Pharmaceutical Commerce Magazine and ... Fin Group is a management and technology consulting firm ...
    (Date:10/22/2014)... Tara Haelle HealthDay Reporter ... drinking among young adult men may lead to increased blood ... didn,t cause a similar rise in blood pressure for young ... fact, when young adult women drank lightly or moderately, their ... study found. "This finding parallels studies in older adult ...
    (Date:10/20/2014)... October 20, 2014 The newly updated ... source of thousands of facts, figures and forecasts on ... 68 medical sector forecast categories the Worldwide Medical ... regional and national views on the worldwide medical market ... The report gives you data for 2010-2019, covering each ...
    (Date:10/20/2014)... (PRWEB) October 20, 2014 Women’s health ... in Obstetrics & Gynecology of Columbus, Inc., A Division ... healthcare services to more than 100,000 patients annually. Dr. ... all ages and stages of a women’s life. She ... locations in Westerville and Dublin. , Dr. Murphy ...
    Breaking Medicine News(10 mins):Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:Rich Carlson and Marc Duey to Hold Workshop at CBI’s Specialty Pharmacy and Distribution Networks Conference 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 2Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 3
    ... , SINGAPORE, June 4 /PRNewswire-Asia/ ... industry will have a unique platform to gain business ... and Congress,2009. According to market analysts, the medical tourism ... market alone will generate revenue,of more than US$4.4 billion ...
    ... 4 Abbott (NYSE: ABT ) and ... New Drug Application (NDA) to the U.S. Food and ... treatment of mixed dyslipidemia, a combination of two or ... cholesterol), high triglycerides and low HDL-cholesterol (the "good" cholesterol). ...
    ... Sheets: GOHE) announced today that the company has entered into a ... of a source of high pH water from a premier aquifer. ... annually of this healthy water. , , The water has ... significant natural anti oxidants. , , Charlie Caudle, CEO of ...
    ... June 4 /PRNewswire/ -- US Oncology, ... aggregate principal amount of senior secured notes to qualified institutional ... of 1933, as amended (the "Securities Act") and outside the ... Act. , , The company plans to use the ...
    ... 4 Prescribing Reference LLC is pleased to announce that the ... medical professionals as a free download for ... www.empr.com/download ). The MPR Mobile & Desktop Edition ... Microsoft Vista. , , For over 24 years, medical professionals ...
    ... Advisors, MISSION Skincare(TM) , , NEW YORK, June 4 ... skincare products, is pleased to announce that Brian B. Adams, ... of the world,s most-esteemed athletes as the latest addition to ... of the Board of Advisors, Dr. Adams will play an ...
    Cached Medicine News:Health News:Singapore to Host Inaugural Healthcare Travel Exhibition & Congress 2Health News:Singapore to Host Inaugural Healthcare Travel Exhibition & Congress 3Health News:Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD(TM), an Investigational Treatment for Mixed Dyslipidemia 2Health News:Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD(TM), an Investigational Treatment for Mixed Dyslipidemia 3Health News:Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD(TM), an Investigational Treatment for Mixed Dyslipidemia 4Health News:Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD(TM), an Investigational Treatment for Mixed Dyslipidemia 5Health News:Go Healthy Enters Letter of Intent to Acquire Premium Water Source 2Health News:US Oncology, Inc. Announces $465 Million Senior Secured Notes Offering 2Health News:MPR Drug Database Available as a Free Download for Mobile Devices, Including BlackBerry and Palm 2Health News:Dr. Brian B. Adams to Join the 'MISSION' 2Health News:Dr. Brian B. Adams to Join the 'MISSION' 3
    ...
    ... on decades of experience, the SSD-1000 is ... system. It uses our advanced technologies and ... Using the same technology as our more ... capabilities in a compact and mobile setting., ...
    ... Harmonic Echo technology constructs images using ... less artifacts and noise than fundamental-frequency ... technology to transmit distortion-free, fundamental-frequency ultrasound ... beam is a pure sinusoidal wave, ...
    ... Topical Skin Adhesive gives you new options ... intended for topical application only to hold ... from surgical incisions, including punctures from minimally ... lacerations. DERMABOND adhesive may be used in ...
    Medicine Products: